Static Chart Enlivex Therapeutics Ltd.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-07-01 EDT			5-day change	1st Jan Change
1.38 ^USD	-2.82%		-2.13%	-48.89%

06-24	Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial	MT
06-24	Enlivex Therapeutics Ltd. Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis	CI

Duration

Period